CKM’s Leadership
Carl Sheeley
President and CEO
As a chemical engineer with more than 30 years of experience exclusively in fine chemical manufacturing, Carl understands what it takes to go from an initial development process to competitive commercial manufacturing. He has done this hundreds of times.
Identifying opportunities with high potential for success comes naturally to Carl. Having worked for Pfizer, the largest drug company in the world, Carl learned numerous world-class scale-up and commercialization practices. This experience helped Carl to then build Fontarome Chemical, Inc. from less than US $1 million to more than US $10 million in sales in just four years.
Carl understands what is at stake with every product. Your success requires more than just a competitive commercial process. You need to have security of supply, regulatory confidence, rigorous quality control and assurance, and a tangible continuous improvement plan. At CKM, Carl works to ensure that every one of his partners are covered and set up for success. As a CKM partner you can expect this, and more.
Timothy Waldoch
Director of Operations
As head of operations at CKM, Tim is all about the details. With more than 25 years of experience in the receiving, manufacturing, packaging, shipping, and warehousing of pharmaceutical, aroma and other fine chemicals it’s pretty clear to see why.
He is well-versed/trained in cGMP, Hazardous Materials, DOT, IATA, HM 181, HM 215A, HM, and HM 126F regulations. Tim single-handedly built the packaging and shipping departments at Fontarome, taking them from nonexistent to over 20 shipments per day, and was part of the leadership team that grew that company from less than US $1 million to US $10 million in sales in less than four years.
A team player through and through, Tim is often cited as having exceptional commitment, unquestionable ethics, and incredible dedication and loyalty. He is your “go to” when you need things to get done right. Tim is also very mechanically inclined. When he isn’t managing operations at CKM, he is putting his skills to work restoring classic American cars, including a 1931 Model A Ford.
Dr. Scott Harring
Director - Research and Development
Dr. Harring is an accomplished chemist, well versed in the art of synthetic organic chemistry, specializing in scale up of APIs and fine chemicals. Having earned his Ph.D in organic chemistry from the University of Minnesota, he has over 25 years of experience in fine chemical development and commercialization. He has worked for a number of pharmaceutical companies including Pfizer (G.D. Searle), MediChem, Mallinckrodt, and Fontarome.
While at Fontarome, Dr. Harring developed the first competitive, commercial synthesis (multi-step, non-linear) for pure Capsaicin, the hottest food ingredient at the time. He also worked closely with CEO Carl Sheeley to lead the R&D team that helped grow Fontarome from less than US $1 million to US $10 million in sales in less than four years.
At CKM, Dr. Harring oversees the R&D team and also functions as a bench chemist and exceptional technical manager.
CKM’s Advisors
CKM is equipped with a team of trusted advisors to help spark scientific creativity, ensure best practices and guide strategic business decisions. Currently CKM is advised by a Scientific Advisory Board and a Corporate Advisory Board. Both of these advisory boards are vital support teams that constantly generate added value for CKM’s partners.
CKM’s Scientific Advisory Board is exclusively comprised of highly accomplished Chemists, whose 150 years of cumulative experience provides a deep knowledge base from which CKM’s full-time R&D staff can draw from. CKM routinely collaborates with its Scientific Advisory Board to ensure that CKM’s partners are getting exceptional IP generation on their products/processes.
SCIENTIFIC ADVISORY BOARD
Dr. Greg Reid
CEO - ChemDev Solutions
Dr. Daryl Sauer
Professor - University of WI (Parkside)
Dr. Scott Duncan
Director of CMC - Centrexion Therapeutics Corp.
Mariano Gascon
VP of Research and Development - Sensapure
Dr. Michel Combe
Consultant
CKM‘s Corporate Advisory Board is exclusively comprised of senior level and accomplished executives with complementary skill sets that will collectively guide/assist Carl Sheeley in driving CKM forward. The Corporate Advisory Board bring best practices from multiple industries to provide CKM and its partners with the highest value possible.
CORPORATE ADVISORY BOARD
Joseph M. Feldman
President - Joseph Feldman Associates
Sarah Fracek
Director of Marketing & Brand Strategy - Kane Communications Group
Dr. Jeffrey M. Evans
CEO - Bionique Testing Laboratories, Inc.